Besides, the phenotype of DPP4−/− mice with high GLP-1 level at born but showed normal fasting blood glucose levels (21) and clinical phenomenon of T2DM patients with GLP-1 analogs but high glucose levels could also partly explain the clinical characterizations of p.V486M carriers. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.